Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Friday, June 23, 2023

Muscular dystrophy breakthrough: FDA approves first-ever gene therapy for rare childrens disease

 June 23, 2023     Health, Health News Today on Fox News     No comments   

The Food and Drug Administration (FDA) has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in children from age 4 through 5 years of age.

Pediatric patients who have a confirmed mutation in the DMD gene and do not have any preemptive medical conditions will have access to the drug, called Elevidys.

"Today’s approval addresses an urgent unmet medical need and is an important advancement in the treatment of Duchenne muscular dystrophy, a devastating condition with limited treatment options, that leads to a progressive deterioration of an individual’s health over time," said Peter Marks, M.D., PhD, director of the FDA’s Center for Biologics Evaluation and Research in Silver Spring, Maryland, in a press release issued by the FDA. 

BREAKTHROUGH FOR MULTIPLE SCLEROSIS SUFFERERS MAY INVOLVE HELPFUL HORMONE: ‘PATIENTS SHOULD REMAIN OPTIMISTIC’

"The FDA remains committed to facilitating the development of innovative new therapies to reduce the impact of debilitating diseases and to improve outcomes and quality of life for those affected," he added.

DMD is a rare muscle disorder that affects around one in every 3,500 male births globally, according to the National Organization for Rare Disorders (NORD). 

Females are rarely affected.

Over time, those with the disease will experience weakening and deterioration of the muscles in the pelvic region, followed by the same effect in the shoulders, torso, forearms and other areas.

As the disease progresses, most patients will require a wheelchair by the time they reach adolescence.

Symptoms usually become apparent between 3 and 6 years of age. 

BILLS' NYHEIM HINES OPENS UP ABOUT FAMILY MEMBERS' STRUGGLES WITH MUSCULAR DYSTROPHY, HOPES TO INSPIRE PEOPLE

The symptoms may include trouble walking and running, fatigue and learning difficulties.

In advanced stages, potentially serious complications include heart disease and trouble breathing. 

People with this disorder have a mutation in the DMD gene on their X chromosome, which regulates the production of a protein called dystrophin that helps with muscle movement in the body and heart. 

The mutation prevents the creation of this protein, ultimately causing muscle weakness and mobility issues.

Current treatments for DMD aim to improve symptoms on an individual basis — but they do not address the genetic cause.

Cortisteroid medications, such as prednisone, are commonly prescribed to help slow the progression of muscle weakness, according to NORD.

Targeted stretching exercises and physical therapy can also help patients build muscle strength.

To aid in mobility, many children with the disease often rely on braces, canes and wheelchairs.

Elevidys, made by Sarepta Therapeutics, Inc. in Cambridge, Massachusetts, is a gene therapy that triggers the production of Elevidys micro-dystrophin, a shortened protein that replaces the dystrophin that is lacking in muscular dystrophy patients, per the FDA’s announcement.

The gene therapy is given as a single-dose injection.

GOT A WEAK GRIP? THAT MIGHT MEAN A SHORTER LIFE, STUDY SAYS

The approval was granted through the FDA’s Accelerated Approval pathway, which fast-tracks access to a drug when there is an "unmet medical need" — and when the medication is likely to relieve patients’ symptoms, improve their quality of life and/or extend their survival.

The approval was based on data from a two-part study in which one group of 4- to 5-year-olds with DMD was treated with Elevidys and another group received a placebo. 

After a 48-week observation, the participants who received Elevidys showed an increase in the Elevidys micro-dystrophin protein in their DMD genes.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"In making this decision, the FDA considered the potential risks associated with the drug, the life-threatening and debilitating nature of the disease for these children, and the urgent unmet medical need," the announcement noted.

Next, the FDA will require Sarepta Therapeutics to conduct another study to measure whether Elevidys improves physical function and mobility in patients as a means of demonstrating clinical benefit.

Some potential side effects of Elevidys include nausea, vomiting, fever, low blood platelet count and acute liver injury, the FDA stated. 

Less common risks include muscle inflammation and heart disease.



from Health News Today on Fox News https://ift.tt/k0CAdlf
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • FOX NEWS: Rep. Donalds: CDC is creating more mask hesitancy with rhetoric Rep. Donalds: CDC is creating more mask hesitancy with rhetoric Florida Republican discusses the latest CDC mask guidelines on ‘Fox News Primetime… Read More
  • FOX NEWS: Dr. Marc Siegel highlights reasons behind CDC's new mask guidance Dr. Marc Siegel highlights reasons behind CDC's new mask guidance Fox news contributor discusses the delta variant and COVID vaccine on 'Special R… Read More
  • FOX NEWS: Rep. Donalds: Making already vaccinate people wear masks 'makes no sense at all' Rep. Donalds: Making already vaccinate people wear masks 'makes no sense at all' Florida Republican discusses the latest CDC mask guidelines on ‘F… Read More
  • FOX NEWS: Ingraham: The day Fauci became president Ingraham: The day Fauci became president 'The Ingraham Angle' host says Biden made a major mistake by not getting rid of him via FOX NEWS https:/… Read More
  • FOX NEWS: Mark Levin slams CDC mask guidelines: That's not science, that's stupidity Mark Levin slams CDC mask guidelines: That's not science, that's stupidity Levin weighs in on Nancy Pelosi's Jan. 6 commission and the new CDC mas… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • FOX NEWS: Losing weight could reduce breast cancer risk for women over 50, study finds
    Losing weight could reduce breast cancer risk for women over 50, study finds Overweight women over the age of 50 could see a reduction ...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD

Recent Posts

Categories

  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • May 2025 (23)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • FOX NEWS: Losing weight could reduce breast cancer risk for women over 50, study finds
    Losing weight could reduce breast cancer risk for women over 50, study finds Overweight women over the age of 50 could see a reduction ...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates